KLK3 and prostate carcinoma: The purpose of this study was to compare rates of BF between well-matched cohorts of patients with prostate cancer who received two common primary treatment modalities, permanent prostate brachytherapy (PPB) or RRP, as a function of varying PSA nadir plus “X”.